BIOCON:NSE
Biocon Ltd
349,20 INR
arrow_downward
-0,80%(-2,80) 1D
16-окт., 15:30:00 GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BIOCON...
Open
352,60 INR
High
353,00 INR
Low
348,00 INR
Mkt. cap
568,79 млд
Avg. vol.
2,97 млн
Volume
1,88 млн
Dividend
0,14%
Quarterly dividend
0,12 INR
Ex-dividend date
2026-ж., 3-июл.
P/E ratio
103,38
52-wk high
447,15 INR
52-wk low
337,70 INR
EPS
3,38 INR
Shares outstanding
600,00 млн
No. of employees
16 миң
Open
352,60 INR
High
353,00 INR
Low
348,00 INR
Mkt. cap
568,79 млд
Avg. vol.
2,97 млн
Volume
1,88 млн
Dividend
0,14%
Quarterly dividend
0,12 INR
Ex-dividend date
2026-ж., 3-июл.
P/E ratio
103,38
52-wk high
447,15 INR
52-wk low
337,70 INR
EPS
3,38 INR
Shares outstanding
600,00 млн
No. of employees
16 миң
News stories
From web sources and news partners
Moomoo
·
1 саат мурун
Dow Jones Top Company Headlines at 7 PM ET: Tesla's New Roadster Takes Flight After Nearly a Decade of Delays | CoreWeave ...
Investing News Network
·
1 саат мурун
Kopin to Host Live YouTube "Ask Me Anything" Panel from Nasdaq MarketSite on the Future of AI Infrastructure
BigGo Finance
·
21 мүнөт мурун
Nasdaq Plunges Over 2% in a Day as Oil Prices Top $100
MarketWatch
·
3 саат мурун
Don’t buy this dip: Several signs suggest there’s more pain ahead for tech stocks
Profile
Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, with U.S. headquarters in Bridgewater, New Jersey. Founded by Kiran Mazumdar-Shaw in 1978 as a partner to the Irish brewing enzyme manufacturer Biocon Biochemicals Ltd., the company manufactures generic active pharmaceutical ingredients that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics, and branded drugs such as biosimilar insulins and antibodies for the Indian domestic market. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.
Biocon's formulations for the Indian market include metabolics, oncology, immunotherapy, and nephrology products. Some of Biocon's key brands in India include INSUGEN, BASALOG, BIOMAb EGFR, BLISTO, CANMAb, Evertor, TACROGRAF, ALZUMAb and KRABEVA.
Syngene International Limited is a publicly listed subsidiary of Biocon, operating in the contract research and development organization. Wikipedia
About Biocon Ltd
CEOShreehas P Tambe
Employees16,4 миң
Founded1978-ж., 29-ноя.
HeadquartersБенгалуру, Карнатака, Индия
Sector-
Websitebiocon.com